Assertio Holdings Inc 's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Assertio Holdings Inc 's ROA in the first quarter of 2026?
Assertio Holdings Inc recorded a cumulative net loss of $-36 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -13.32%.

However, within the Healthcare sector 324 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 3313, from total ROA ranking in the fourth quarter of 2025 at 3768.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	-26.23 %	-6.24 %	15.86 %	-2.04 %	1.58 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-36	-30	-29	-43	-31
Return On Assets (TTM)	-13.32 %	-10.59 %	-9.93 %	-15.45 %	-10.87 %
ASRT's Total Ranking	# 3313	# 3768	# 3285	# 3459	# 3347
Total Assets (TTM) in million	211	267	320	274	286
Seq. Total Assets Change	-20.85 %	-16.51 %	16.82 %	-4.43 %	0.59 %
Seq. Net Income Change	-	-	-	-	-

ASRT's 5 Years Annual ROA >> Back to ASRT Management Effectiveness >> Compare ASRT ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 117
Sector	# 325
Overall	# 3286

Return On Assets Statistics
High	Average	Low
31.36 %	-10.07 %	-112.43 %
(Dec 31 2022)		(Jun 30 2024)

Financial Statements
Assertio Holdings Inc 's Assets	$ 211 million	ASRT's Balance sheet
Assertio Holdings Inc 's Income	$ -19 million	Quarterly ASRT's Income Statement
ASRT's Income by Division		See ASRT's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-6.24 %	-0.59 %	-30.8 %	26.75 %	7.67 %
Total Assets in million	267	285	286	414	327
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-30	-22	-332	110	-1
Annual Return On Assets	-11.38 %	-7.58 %	-115.89 %	26.49 %	-0.39 %

ASRT's 5 Years Annual ROA >> Back to ASRT Management Effectiveness >> Compare ASRT ROA to its Competitors

More Return On Assets Ratios
ASRT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ASRT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ASRT's Competitors
Subscribers only: Roa for Assertio Holdings Inc 's Suppliers
Subscribers only: Return On Assets for ASRT's Customers

You may also want to know
ASRT's Roi	ASRT's Inventory Turnover Ratio	ASRT's Growth Rates	ASRT's Dividend Comparisons
	ASRT's Profitability Ratios	ASRT's Asset Turnover Ratio	ASRT's Dividend Growth
ASRT's Roe	ASRT's Valuation Ratios	ASRT's Financial Strength Ratios	ASRT's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector

ROA

Date modified: 2026-08-29T17:42:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.